- Neuropeptide modulation of oxazolone-induced delayed-type hypersensitivity reaction in mouse ear
E Pinter; A Banvolngyi; Z Helyes; A Grant; J Szolcsanyi; S D Brain
- Neuropeptide S increases fMLP-stimulated CD11b levels in eosinophils from patients with elevated IgE
Ilmarinen Salo P, Moilanen E, Pulkkinen V, Saarelainen S, Laitinen T, Kere J, Kankaanranta H
- Neuropeptides of the VIP family inhibit glioblastoma cell invasion through interaction with the VPAC1 receptor
Cochaud S, Meunier AC, Monvoisin A, Chadeneau C, Muller JM
- Neuropeptide Y (NPY) Y1 receptors, constrained as dimers by bimolecular fluorescence complementation, undergo rapid agonist-promoted internalisation
Kilpatrick L, Holliday N
- Neuropeptide Y (NPY) Y1/Y5 receptor heterodimers constrained by bimolecular fluorescence complementation (BiFC) exhibit altered Y5 antagonist pharmacology
LE Kilpatrick, ND Holliday
- Neuropharmacological evaluation of Endemic Aloes from Mascarene Islands
D Lobine, J Govinden-Soulange, J Bertacchi, K Lindsey, P Chazot
- Neuropharmacology and toxicity of synthetic cannabinoid legal highs (novel psychoactive substances) tested in rat brain slices and neural stem cells
C Davidson, V Barrese, J Opacka-Juffry, N Dutta, E Torok, L Williams, F Molina-Holgado
- Neuroprotection afforded by 17beta-estradiol in a rat model of transient middle cerebral artery occlusion implicates modulation of fatty acid amide hydrolase (FAAH) activity
Amantea D, Mazzei C, Bari M, Spagnuolo P, Pasquariello N, Corasaniti MT, Bagetta G, Maccarrone M
- Neuroprotection in an experimental model of multiple sclerosis via fatty acid amide hydrolase or monoacylglycerol lipase inhibition
G Pryce, R Graves, M R Elphick, G Giovannoni, D Baker
- Neuroprotection in an experimental model of multiple sclerosis via fatty acid amide hydrolase or monoacylglycerol lipase inhibition
G Pryce, R Graves, M R Elphick, G Giovannoni, D Baker
